Table 1.

Patient characteristics (n=26)

Age, median (range), y	48 (19–77)
Male, n (%)	19 (73.1)
Disease duration of UC, median (range), y	5.2 (1.0–31.0)
CAI score, median (range)	6 (4–14)
UCEIS, median (range)	4 (3–7)
CRP, median (range), mg/dL	0.22 (0.02–7.98)
Disease type, n (%)
Pancolitis	19 (73.1)
Left-sided colitis	7 (26.9)
Proctitis	0 (0)
Steroid, n (%)
Refractory	7 (27.0)
Dependency	11 (42.3)
Concomitant medication for UC, n (%)
5-ASA	20 (77.0)
Steroids	14 (53.8)
Immunosuppressants	8 (30.8)
Prior TNFα antagonists therapy, n (%)	13 (50)
Prior failure of TNFα antagonists, n (%)
Inadequate response	8 (61.5)
Loss of response	3 (23.1)
Intolerance	2 (15.4)

UC: ulcerative colitis

CAI: Clinical Activity Index

UCEIS: Ulcerative Colitis Endoscopic Index of Severity

CRP: C-reactive protein

5-ASA: 5-aminosalicylic acid

TNFα: tumor necrosis factors alpha